Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progression-Free Survival”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT00577109
What this trial is testing

Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche
Large-scale testing (Phase 3)Looking for participantsNCT07342478
What this trial is testing

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

Who this might be right for
CLL / SLLCLL (Chronic Lymphocytic Leukemia)CLL, Refractory+5 more
Newave Pharmaceutical Inc 306
Large-scale testing (Phase 3)Study completedNCT00718549
What this trial is testing

Assess the Effect of Maintenance Treatment With Rituximab Versus No Treatment in Participants With Progressive B-Cell Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 128
Testing effectiveness (Phase 2)Study completedNCT00748358
What this trial is testing

An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic NeoplasmsNeoplasms, Hormone-DependentTumor Markers, Biological+2 more
Assistance Publique - Hôpitaux de Paris 50
Not applicableUnknownNCT04331912
What this trial is testing

PFS and OS of Patients With Advanced Neuroendocrine Cancer (NEN) After Systemic Treatment

Who this might be right for
Neuroendocrine Tumors
University of Warmia and Mazury 100
Testing effectiveness (Phase 2)Study completedNCT01814475
What this trial is testing

Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis

Who this might be right for
Myelofibrosis
Gruppo Italiano Trapianto di Midollo Osseo 62
Testing effectiveness (Phase 2)Study completedNCT03769935
What this trial is testing

Maintenance Therapy for Small-cell Lung Cancer

Who this might be right for
Progression Free Survival
Qingdao Central Hospital 90
Large-scale testing (Phase 3)UnknownNCT02416739
What this trial is testing

Anticancer Activity of Nicotinamide on Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
Il Yeong Park, Ph.D. 110
Testing effectiveness (Phase 2)UnknownNCT00839111
What this trial is testing

Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment

Who this might be right for
Colorectal Neoplasms
Fudan University 43
Testing effectiveness (Phase 2)Study completedNCT01480986
What this trial is testing

IPO-NEC Trial:Study on the Efficacy and Safety Using Sequential IP Therapy and Oct Lar in the Treatment of Advanced GI NEC

Who this might be right for
Progression Free Survival of the Treatment
Peking University 40
Large-scale testing (Phase 3)Study completedNCT01837251
What this trial is testing

Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer

Who this might be right for
Recurrent Platinum-sensitive Ovarian Cancer
AGO Research GmbH 682
Testing effectiveness (Phase 2)Ended earlyNCT00773383
What this trial is testing

The Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy.

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 35
Not applicableActive Not RecruitingNCT05862051
What this trial is testing

RESOLUTE Trial Aims to Investigate the Value of Adding Local Ablative Treatment to Standard Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer

Who this might be right for
Colorectal CancerOligometastatic Disease
Australasian Gastro-Intestinal Trials Group 6
Not applicableLooking for participantsNCT06283927
What this trial is testing

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma, IDH-wildtype+5 more
Jasper Gerritsen 464
Not applicableStudy completedNCT03601689
What this trial is testing

Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma

Who this might be right for
Rectal Neoplasms
Moroccan Society of Surgery 84
Not applicableEnded earlyNCT01277120
What this trial is testing

An Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Colorectal Cancer (CRONOS 1)

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 174
Not applicableStudy completedNCT07363434
What this trial is testing

A Real-world Study of Indian Patients With Advanced Breast Cancer Treated With Ribociclib

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 335
Testing effectiveness (Phase 2)Ended earlyNCT03050814
What this trial is testing

Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004

Who this might be right for
Colorectal TumorsColorectal NeoplasmsColorectal Carcinoma+2 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Looking for participantsNCT06826092
What this trial is testing

Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy

Who this might be right for
Progression-Free Survival
Kaohsiung Medical University Chung-Ho Memorial Hospital 110
Testing effectiveness (Phase 2)UnknownNCT00886028
What this trial is testing

Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
National Institute of Cancerología 31
Next Page